Eugene Schneider

Eugene Schneider (senior executive) discloses dealings in Ionis Pharmaceuticals Inc to SEC (Form 4). Between 15 October 2021 and 26 June 2026, the trades on record add up to 19 filings.

Every open-market trade on record is a sale: 4 sales worth €809k. The totals exclude 1 filing filed without an amount. Outside the open market, there are 4 share grants and 11 option exercises. In 2026 alone, the filings show no purchases and 2 sales.

The latest filing, published on 30 June 2026, reports an option exercise in Ionis Pharmaceuticals Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.